Examining the influence of illness perception and financial toxicity on the quality of life of prostate cancer patients
Tóm tắt
Cancer of the prostate (CaP) is a public health problem that affects the male genitourinary system causing a significant threat to men’s quality of life (QoL). Experiencing financial constraints and poor illness perception may further compromise the QoL of men with CaP. Aim: To examine the relationship between financial toxicity and illness perception with quality of life in men with CaP. The descriptive cross-sectional study used simple random sampling technique to recruit 173 men with CaP from four tertiary health facilities in Nigeria. Data were collected with the comprehensive score for financial toxicity (COST-FACIT), the brief illness perception questionnaire (Brief IPQ) and the functional assessment of cancer therapy-prostate (FACT-P). Analysis of data was carried out using analysis of variance, correlation and hierarchical regression analyses. The 173 participants had an average age of 71.57 ± 11.18, and 53.18% had one comorbid disease. Significant difference was found in overall QoL based on treatment site and number of comorbid diseases (P < 0.01). QoL had a significant inverse relationship with all the illness perception variables and a significant linear relationship with lower financial toxicity (P < 0.01). Furthermore, financial toxicity (P < 0.05) and four illness perception variables: consequences, identity, concern and illness understanding (P < 0.01), had significant individual influences on QoL of men with CaP. Quality of life in men with CaP may be improved through mitigating the financial toxicity associated with accessing care and providing appropriate counseling about the illness and what to expect following prostate cancer diagnosis and during treatment.
Tài liệu tham khảo
Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M et al (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136(5):E359–386
Walsh P, Worthington JF (2012) Guide to surviving prostate cancer, 3rd edn. Hachette Book Group, New York
Skolarus TA, Holmes-Rovner M, Hawley ST, Dunn RL, Barr KL, Willard NR et al (2012) Monitoring quality of life among prostate cancer survivors: the feasibility of automated telephone assessment. Urology 80(5):1021–1026
Boyle DA (2006) Survivorship. Clin J Oncol Nurs 10(3):407–416. https://doi.org/10.1188/06.CJON.407-416
McLean G, Gunn J, Wyke S, Guthrie B, Watt GCM, Blane DN et al (2014) The influence of socioeconomic deprivation on multimorbidity at different ages: a cross-sectional study. Br J Gen Pract 64(624):e440–447
Sarfati D, Koczwara B, Jackson C (2016) The impact of comorbidity on cancer and its treatment. CA Cancer J Clin 66(4):337–350
Sharp L, Carsin AE, Timmons A (2013) Associations between cancer related financial stress and strain and psychological wellbeing among individuals living with cancer. PsychoOncology 22(4):745–755
Sharp L, Timmons A (2016) Pre-diagnosis employment status and financial circumstances predict cancer-related financial stress and strain among breast and prostate cancer survivors. Support Care Cancer 24(2):699–709
O’Connor JM, Kircher SM, de Souza JA (2016) Financial toxicity in cancer care. J Community Support Oncol 14:101–106. https://doi.org/10.12788/jcso.0239. PMID: 27058866.
Zafar SY, Peppercorn JM, Schrag D et al (2013) The financial toxicity of cancer treatment: a pilot study assessing out-of-pocket expenses and the insured cancer patient’s experience. Oncologist 18:381–390
Delgado-Guay M, Ferrer J, Rieber AG et al (2015) Financial distress and its associations with physical and emotional symptoms and quality of life among advanced cancer patients. Oncologist 20:1092–1098
Lathan CS, Cronin A, Tucker-Seeley R, Zafar SY, Ayanian JZ, Schrag D (2016) Association of financial strain with symptom burden and quality of life for patients with lung or colorectal cancer. J Clin Oncol 34(15):1732–1740
Leventhal H, Brissette I, Leventhal EA (2003) The common-sense model of self-regulation of health and illness. In: Cameron LD, Leventhal H (eds) The self-regulation of health and illness behaviour. Routledge, New York
Leventhal H, Phillips LA, Burns E (2016) The common-sense model of self-regulation (CSM): a dynamic framework for understanding illness self-management. J Behav Med 39:935–946
Hagger MS, Koch S, Chatzisarantis NLD, Orbell S (2017) The common sense model of self-regulation: meta-analysis and test of a process model. Psychol Bull 143:1117–1154
Broadbent E, Wilkes C, Koschwanez H, Weinman J, Norton S, Petrie KJ (2015) A systematic review and meta-analysis of the brief illness perception questionnaire. Psychol Health 30:1361–1385
Dempster M, Howell D, McCorry NK (2015) Illness perceptions and coping in physical health conditions: a meta-analysis. J Psychosom Res 79:506–513
Abubakari AR, Cousins R, Thomas C, Sharma D, Naderali EK (2016) Sociodemographic and clinical predictors of self-management among people with poorly controlled type 1 and type 2 diabetes: the role of illness perceptions and self-Efficacy. J Diabetes Res 2016:6708164
Porreca A, Noale M, Artibani W, Bassi PF, Bertoni F, Bracarda S et al (2018) Disease specific and general health-related quality of life in newly diagnosed prostate cancer patients: the ProsIT CNR study. Health Qual Life Outcomes 16(1):122
Kikkawa K, Iba A, Kohjimoto Y, Noda Y, Sonomura T, Hara I (2018) Impact of age on quality of life in patients with localized prostate cancer treated with high-dose rate brachytherapy combined with external beam radiotherapy. Int J Urol 25(4):366–371
Kurian CJ, Leader AE, Thong MS, Keith SW, Zeigler-Johnson CM (2018) Examining relationships between age at diagnosis and health-related quality of life outcomes in prostate cancer survivors. BMC Public Health 18(1):1060
Mardani A, Razi SP, Mazaheri R, Dianatinasab M, Vaismoradi M (2020) Health-related quality of life in prostate cancer survivors: implications for nursing care. Int J Caring Sci 13(2):1322–1332
Üstündag S, Zencirci AD (2015) Factors affecting the quality of life of cancer patients undergoing chemotherapy: A questionnaire study. Asia Pac J Oncol Nurs 2:17–25
Yýldýz Ý, Özgüroðlu M, Toptaş T, Turna H, Sen F, Yýldýz M (2013) Patterns of complementary and alternative medicine use among Turkish cancer patients. J Palliat Med 16:383–390
Kao Y-L, Tsai Y-S, Ou F-Y, Syu Y-J, Ou C-H, Yang W-H, Cheng H-L, Tzai T-S, Wang J-D (2015) Determinants of quality of life in prostate cancer patients: a single institute analysis. Urol Sci 26(4):254–258
Knight SJ, Latini DM, Hart SL, Sadetsky N, Kane CJ, DuChane J et al (2007) Education predicts quality of life among men with prostate cancer cared for in the department of veterans affairs. Cancer 109:1769–1776
Bellardita L, Rancati T, Alvisi MF, Villani D, Magnani T, Marenghi C et al (2013) Predictors of health-related quality of life and adjustment to prostate cancer during active surveillance. Eur Urol 64:30–36
Pereira RF, Daibs YS, Tobias-Machado M, Pompeo AC (2011) Quality of life, behavioral problems, and marital adjustment in the first year after radical prostatectomy. Clin Genitourin Cancer 9:53–58
Ferguson J, Aning J (2015) Prostate cancer survivorship: a nurse-led service model. Br J Nurs 24(Sup18):S14–S21
Jedy-Agba E, Odutola M, Oga E and Adebamowo C (eds) (2016) Cancer in Nigeria, 2009–2013. Nigerian National System of Cancer Registries. ISBN number: 978-978-955-030-2
Oluwole OP, Rafindadi AH, Shehu MS, Samaila MOA (2015) A ten-year study of prostate cancer specimens at Ahmadu Bello University Teaching Hospital (A.B.U.T.H), Zaria, Nigeria. Afr J Urol 21(1):15–18
Esper P, Mo F, Chodak G et al (1997) Measuring quality of life in men with prostate cancer using the functional assessment of cancer therapy-prostate instrument. Urology 50:920–928
Broadbent E, Petrie KJ, Main J, Weinman J (2006) The brief illness perception questionnaire. J Psychosom Res 60(6):631–637
de Souza JA, Yap BJ, Hlubocky FJ et al (2014) The development of a financial toxicity patient-reported outcome in cancer: the COST measure. Cancer 120:3245–3253
de Souza JA, Yap BJ, Wroblewski K, Blinder V, Araujo FS, Hlubocky FJ, Nicholas LH, O’Connor JM, Brockstein B, Ratain MJ, Daugherty CK, Cella D (2017) Measuring financial toxicity as a clinically relevant patient-reported outcome: the validation of the comprehensive score for financial toxicity (COST). Cancer 123(3):476–484
Fischer MJ, Inoue K, Matsuda A, Kroep JR, Nagai S, Tozuka K, Momiyama M, Weijl NI, Langemeijer-Bosman D, Ramai S, Nortier J, Putter H, Yamaoka K, Kubota K, Kobayashi K, Kaptein AA (2017) Cross-cultural comparison of breast cancer patients’ Quality of Life in the Netherlands and Japan. Breast Cancer Res Treat 166(2):459–471. https://doi.org/10.1007/s10549-017-4417-z
Urzúa A, Miranda-Castillo C, Caqueo-Urízar A et al (2013) Do cultural values affect quality of life evaluation? Soc Indic Res 114:1295–1313. https://doi.org/10.1007/s11205-012-0203-9
Zhang T, Shi W, Huang Z et al (2016) Influence of culture, residential segregation and socioeconomic development on rural elderly health-related quality of life in Guangxi. China Health Qual Life Outcomes 14:98. https://doi.org/10.1186/s12955-016-0499-2
Ramsey SD, Blough DK, Kirchhoff AC et al (2013) Washington cancer patients found to be at greater risk for Bankruptcy than people without a cancer diagnosis. Health Aff 32:1143–1152
Fenn KM, Evans SB, McCorkle R et al (2014) Impact of financial burden of cancer on survivors’ quality of life. J Oncol Pract 10:332–339
Richardson EM, Schuz N, Sanderson K, Scott JL, Schuz B (2016) Illness representations, coping, and illness outcomes in people with cancer: a systematic review and meta-analysis. PsychoOncology. https://doi.org/10.1002/pon.4213
Husson O, Thong MS, Mols F, Oerlemans S, Kaptein AA, van de Poll-Franse LV (2013) Illness perceptions in cancer survivors: what is the role of information provision? Psychooncology 22(3):490–498
Clarke LH, Bennett E (2013) You learn to live with all the things that are wrong with you’: gender and the experience of multiple chronic conditions in later life. Ageing Soc 33:342–360
Pierorazio PM, Walsh PC, Partin AW, Epstein JI (2013) Prognostic G leason grade grouping: data based on the modified Gleason scoring system. BJU Int 111(5):753–760
Mapelli P, Picchio M (2015) Initial prostate cancer diagnosis and disease staging—the role of cholinePET–CT. Nat Rev Urol 12(9):510